Rabeprazole-d4

• Description :

  Rabeprazole-d4 is a deuterium labeled Rabeprazole. Rabeprazole is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole induces apoptosis. Rabeprazole acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole can be used for the research of gastric ulcerations and gastroesophageal reflux[1][2][3].

• Product Name Alternative :

  LY307640-d4

• UNSPSC :

  12352005

• Hazard Statement :

  H315, H319, H320

• Target :

  Apoptosis; Isotope-Labeled Compounds; Proton Pump

• Type :

  Isotope-Labeled Compounds

• Related Pathways :

  Apoptosis; Membrane Transporter/Ion Channel; Others

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Cancer; Inflammation/Immunology

• Purity :

  98.18

• Solubility :

  DMSO : 20.83 mg/mL (ultrasonic; warming)

• Smiles :

  COCCCOC(C=CN=C1CS(C2=NC3=C([2H])C([2H])=C([2H])C([2H])=C3N2)=O)=C1C

• Molecular Formula :

  C18H17D4N3O3S

• Molecular Weight :

  363.47

• Precautions :

  H315, H319, H320

• References & Citations :

  Trichomonas Vaginalis

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported

• CAS Number :

  [934295-48-4]